tiprankstipranks

Scott Andrew Smith Insider Profile

4 Followers
Scott Andrew Smith, President and Chief Operating Officer at Celgene, holds 52.21K shares in Celgene (Ticker: CELG), holds ― shares in Titan Pharmaceuticals (Ticker: TTNP), holds 302.41K shares in BioAtla (Ticker: BCAB).
tipranks
Scott Andrew Smith

Scott Andrew Smith
Celgene (CELG)
President and Chief Operating Officer

Ranked #6,044 out of 97,997 Corporate Insiders

Profitable Transactions

83%
5 out of 6 Profitable Transactions

Average Return

+43.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
66.28%
33.72%
0.00%
A breakdown of Scott Andrew Smith's holdings

Insider Roles

Viatris
(VTRS)
CEO, Director
BioAtla
(BCAB)
Director
Titan Pharmaceuticals
(TTNP)
Director
Roles that Scott Andrew Smith holds in companies

Most Profitable Insider Trade

Stock:
BioAtla
(BCAB)
Rating:Informative Sell
Date:Aug 30, 2021 - Aug 30, 2022
Return:+79.60%
The most profitable trade made by Scott Andrew Smith

Scott Andrew Smith's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
CELG
Celgene
Dec 18, 2015
Uninformative Buy
290.74K
$5.65M
Titan Pharmaceuticals
Director
FSTX
F-star Therapeutics
Jan 02, 2020
Uninformative Buy
$266.83K
BioAtla
Jul 01, 2024
Director
Uninformative Sell
2.99K
$514.10K
APGN
Apexigen
Viatris
Mar 05, 2024
CEO, Director
Uninformative Buy
1.07M
$1.01M
List of latest transactions for each holding click on a transaction to see Scott Andrew Smith's performance on stock

Scott Andrew Smith insider profile FAQ

What is the percentage of profitable transactions made by Scott Andrew Smith?
The percentage of profitable transactions made by Scott Andrew Smith is 83%.
    What is the average return per transaction made by Scott Andrew Smith?
    The average return per transaction made by Scott Andrew Smith is 43.70%.
      What stocks does Scott Andrew Smith hold?
      Scott Andrew Smith holds: CELG, TTNP, FSTX, BCAB, APGN, VTRS stocks.
        What was Scott Andrew Smith’s latest transaction?
        Scott Andrew Smith latest transaction was an Uninformative Buy of $290.74K.
          What was Scott Andrew Smith's most profitable transaction?
          Scott Andrew Smith’s most profitable transaction was an Informative Sell of BCAB stock on August 30, 2021. The return on the trade was 79.60%.
            What is Scott Andrew Smith's role in Celgene?
            Scott Andrew Smith's role in Celgene is President and Chief Operating Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.